anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Problem Agitate Solution

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 26,550
Current window 20,281-20,310
Pages 885
Rows per page 30
Arc: Problem Agitate Solutionclear collectionreset all
18 30 60

Arc

20,281-20,310 of 26,550

filter-aware
01
Slide 1
Allarity Therapeutics | Investor Conference Presentation Deck | 23 slidesAllarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
02
Allarity Therapeutics | Investor Conference Presentation Deck | 23 slidesAllarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
03
Allarity Therapeutics | Investor Conference Presentation Deck | 23 slidesAllarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide uses a standard pharmaceutical pipeline grid format.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide uses a network graph to illustrate complexity and a funnel/filter diagram to illustrate the DRP engine process.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
07
The slide uses a process flow to explain the diagnostic mechanism.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
08
The slide highlights clinical validation across 47 trials, split between prospective Phase 2 and retrospective Phase 2/3 studies.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
09
Includes clinical trial references and a stacked bar chart comparing 2019A vs 2026E market size.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
11
Includes a stacked bar chart showing market growth projections for ovarian and pancreatic cancer.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
12
Mentions DRP (Drug Response Predictor) as a companion diagnostic to justify pricing premium.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
13
Includes a stacked bar chart showing market growth from 2019A to 2026E.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
14
The slide uses a box plot to show the distribution of DRP scores between clinical responders and non-responders, with a clear cutoff at 50.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
15
The table uses checkmarks and X marks to highlight the competitive advantage of Stenoparib.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
16
Includes clinical efficacy data (PFS) and commercial context.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
17
The slide uses a dot plot to show biomarker sensitivity distribution and a bar chart to compare ORR outcomes.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
18
The slide uses a timeline framework to visualize clinical trial phases and interim data milestones.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
19
Allarity Therapeutics | Investor Conference Presentation Deck | 23 slidesAllarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
20
Allarity Therapeutics | Investor Conference Presentation Deck | 23 slidesAllarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
21
Allarity Therapeutics | Investor Conference Presentation Deck | 23 slidesAllarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
22
The slide uses a timeline-like structure to organize milestones by drug program.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
23
Allarity Therapeutics | Investor Conference Presentation Deck | 23 slidesAllarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
01
Slide 1
Altair US LLC | Activist Presentation Deck | 38 slidesAltair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
02
Altair US LLC | Activist Presentation Deck | 38 slidesAltair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
03
Uses external analyst quotes to validate the activist's position on valuation.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
04
Altair US LLC | Activist Presentation Deck | 38 slidesAltair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
05
Altair US LLC | Activist Presentation Deck | 38 slidesAltair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
06
The slide uses a three-column structure to present the activist's thesis.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem1 hit
14
The slide uses a 3D protein structure visualization and a heatmap to show mutation differences between Omicron lineages.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
15
The chart uses a logarithmic scale for the y-axis (pVN50 titer).BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
16
The slide outlines three distinct R&D pillars for COVID-19 vaccines.BioNTech | Results Presentation Deck | 32 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit